KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy

52

KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF

Last Price:

$25.25

Seasonality Move:

0.75%

Buy

77

CDTX
Cidara Therapeutics, Inc.

Last Price:

$220.21

Seasonality Move:

11.35%

Buy

52

KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ) is a Buy

Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?

The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $24.91. The Score for KEMQ is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
KEMQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

77

Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

The current Cidara Therapeutics, Inc. [CDTX] share price is $220.31. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KEMQ Stock Price Chart

What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?

The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $24.91

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KEMQ is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

The Cidara Therapeutics, Inc. share price today is $220.31

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

KEMQ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.22	Sell
Relative Strength Index (14 RSI):	35.88	Sell
Chaikin Money Flow:	-3907	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(25.25 - 26.21)	Sell
Bollinger Bands (100):	(23.74 - 26.76)	Sell

CDTX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	17.9	Buy
Relative Strength Index (14 RSI):	84.85	Buy
Chaikin Money Flow:	566238	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(179.97 - 241.41)	Buy
Bollinger Bands (100):	(53.79 - 174.17)	Buy

KEMQ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	25.58	Sell
20-day SMA:	25.57	Sell
50-day SMA:	26.12	Sell
200-day SMA:	22.72	Buy
8-day EMA:	25.41	Sell
20-day EMA:	25.67	Sell
50-day EMA:	25.34	Sell
200-day EMA:	16.04	Buy

CDTX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	220.16	Buy
20-day SMA:	220.01	Buy
50-day SMA:	157.24	Buy
200-day SMA:	71.79	Buy
8-day EMA:	219.83	Buy
20-day EMA:	208.3	Buy
50-day EMA:	169.39	Buy
200-day EMA:	91.98	Buy

KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis

	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17
	Dec
	04	05	08	09	10	11	12	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17
	Dec
	04	05	08	09	10	11	12	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):